Medical AIThe 2013 ACC/AHA Pooled Cohort Equations estimate the 10-year probability of a first hard atherosclerotic cardiovascular event (nonfatal MI, coronary death, or fatal/nonfatal stroke) in adults aged 40 to 79 without known ASCVD. This is a legacy equation: current AHA materials position PREVENT as the race-free tool for contemporary primary-prevention risk estimation.
| Band | Meaning |
|---|---|
| < 5%, low risk | Low 10-year ASCVD risk under the legacy Pooled Cohort Equations. For current primary-prevention decisions, use contemporary guideline-directed risk assessment such as PREVENT and incorporate risk-enhancing factors. |
| 5 to < 7.5%, borderline risk | Borderline risk under the legacy Pooled Cohort Equations. Current decisions should be reconciled with PREVENT-based risk assessment, risk-enhancing factors, and clinician-patient discussion. |
| 7.5 to < 20%, intermediate risk | Intermediate risk under the legacy Pooled Cohort Equations. Do not treat this number as the current standalone decision rule; use current guideline risk assessment and consider coronary artery calcium when the decision is uncertain. |
| >= 20%, high risk | High risk under the legacy Pooled Cohort Equations. Confirm with current guideline-directed risk assessment and manage LDL cholesterol and other risk factors accordingly. |
10-year risk = 1 - S0^exp(sum of (coefficient x ln value) - group mean), using sex- and race-specific coefficients for ln age, ln total cholesterol, ln HDL, ln systolic BP (treated or untreated), smoking, and diabetes, plus age-interaction terms. S0 is the group baseline survival.The Pooled Cohort Equations were developed for the 2013 ACC/AHA cardiovascular risk guideline (Goff et al.). This implementation is an educational legacy tool and is not affiliated with the ACC, AHA, or the original authors. The equations have documented limitations across populations; current AHA materials position race-free PREVENT equations for contemporary primary-prevention risk estimation.
Historically, PCE thresholds of 7.5% and 20% informed statin intensity discussions. Current practice should use contemporary guideline-directed risk assessment, including PREVENT where applicable, plus risk-enhancing factors and patient preference.
The 2013 Pooled Cohort Equations were derived with only those two race-specific coefficient sets, and the White set is applied to all other groups. This is a recognised limitation; the 2023 AHA PREVENT equations were developed partly to remove race from the estimate.
No. The equations estimate the risk of a first event in adults without established atherosclerotic cardiovascular disease. Patients with known ASCVD, LDL >= 190 mg/dL, or familial hypercholesterolaemia are treated on their own indications, not on this score.
Calculators give a number. When the patient in front of you needs the reasoning behind it, with the sources, the product is what does the looking-up.
Medical AI returns evidence-grounded answers backed by real citations. It is a reference tool, and these terms describe how it should and should not be used.
Medical AI is an information and reference tool intended for educational use only. The answers it returns are not medical advice, diagnosis, or treatment. Always consult a qualified doctor or healthcare professional with any question concerning a medical condition.
Medical AI is designed for use by practicing clinicians. It is not intended for direct patient use and is not a substitute for professional clinical judgment. Apply your own training and current guidelines to every decision an answer informs.
We do not collect, store, or process personally identifiable patient information (PHI or PII). Do not enter names, dates of birth, medical record numbers, or any other patient identifiers into the composer.
Medical knowledge evolves rapidly. Citations carry their publication date, so consult the primary source and the most recent clinical guideline before acting on anything material.